Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data

Cancer

Volumn 118, Issue 2, 2012, Pages 333-341

  Jagsi, Reshma ^a   Abrahamse, Paul ^b   Hawley, Sarah T ^b   Graff, John J ^c   Hamilton, Ann S ^d   Katz, Steven J ^b,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ascertainment; Breast cancer; Data quality; Radiation therapy; SEER

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCREDITATION; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SOCIAL STATUS; THERAPY DELAY; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; RADIOTHERAPY; SEER PROGRAM; SELF REPORT;

EID: 84855479656     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26295     Document Type: Article

References (27)

1. National Cancer Institute. Surveillance Epidemiology and End Results. About SEER. Available at: http://seer.cancer. gov/about/. Accessed on July 30, 2010.
2. Yu JB Gross CP Wilson LD Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology. 200923:288-295.
3. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097-1101.
4. Nattinger AB, Hoffman RG, Kneusel RT, Schapira MM. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148-1153.
5. SEER Program Coding and Staging Manual 2010. Available at: http://seer.cancer.gov/manuals/2010/SPCSM-2010-maindoc.pdf Accessed February 11, 2011.
6. Bickell NA, Chassin MR. Determining the quality of breast cancer care: do tumor registries measure up? Ann Intern Med. 2000;132:705-710.
7. Malin JL, Kahn KL, Adams J, et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Nat Cancer Inst. 2002;94:835-844.
8. Martinez SR, Beal SH, Chen SL, et al. Disparities in the use of radiation therapy in patients with local-regionally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2010; 78:787-792.
9. Freedman RA, He Y, Winer EP, Keating NL. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009;27:713-719.
10. Du XL, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis. 2007;17:122-128.
11. Morrow M, Jagsi R, Alderman A, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551-1556.
12. Hawley ST, Griggs JJ, Hamilton AS, et al. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst. 2009;101:1-11.
13. Hamilton AS, Hofer TP, Hawley ST, et al. Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment. Cancer Epidemiol Biomarkers Prev. 2009;18:2022-2029.
14. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual (ed 6). Philadelphia, PA: Lippincott Raven Publishers; 2002.
15. Marin G, Van Oss Marin B. Research With Hispanic Populations. Newbury Park, CA: Sage Publications; 1991.
16. Dillman DA: Mail and Telephone Surveys: The Total Design Method. New York, NY: John Wiley and Sons; 1997.
17. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. J Clin Epidemiol. 1999; 52:463-470.
18. Virnig B, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare linked data. Med Care. 2002; 40(8 suppl):IV-49-IV-54.
19. Jagsi R, Abrahamse P, Morrow M, et al. Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol. 2010;28: 2396-2403.
20. Dragun AE, Huang B, Tucker TC, Spanos WJ. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer. Cancer. 2011; 117:2590-2598.
21. North American Association of Central Cancer Registries. Certification Criteria. Available at: http://www.naaccr.org/Certification/Criteria.aspx. Accessed on February 10, 2011.
22. Hamilton AS, Albertsen PC, Johnson, TK et al. Trends in treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011;107:576-584.
23. Harlan LC, Abrams J, Warren JL, et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. J Clin Oncol. 2002;20:1809-1817.
24. Liu Y, Diamant A, Thind A, Maly RC. Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat. 2010;119:745-751.
25. Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol. 2005;58:364-369.
26. Phillips KA, Milne RL, Buys S, et al. Agreement between self-reported breast cancer treatment and medical records in a population-based breast cancer family registry. J Clin Oncol. 2005;23:4679-4686.
27. Thornton M, ed. Standards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Record Layout Version 12.1. 15th ed. Springfield, IL: North American Association of Central Cancer Registries; 2010.